bostonrealestatetimes.com
Aileron Therapeutics, a clinical-stage firm in the field of stapled peptide
therapeutics for cancers and other diseases, will relocate from Cambridge to
18,609 square feet of space, while Kala Pharmaceuticals, Inc. (NASDAQ: KALA), a
biopharmaceutical company focused on the development and c…
over 6 years ago